Nicola Currò

4.9k total citations
28 papers, 1.3k citations indexed

About

Nicola Currò is a scholar working on Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Ophthalmology. According to data from OpenAlex, Nicola Currò has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Ophthalmology. Recurrent topics in Nicola Currò's work include Ophthalmology and Eye Disorders (26 papers), Pituitary Gland Disorders and Treatments (14 papers) and Thyroid Disorders and Treatments (8 papers). Nicola Currò is often cited by papers focused on Ophthalmology and Eye Disorders (26 papers), Pituitary Gland Disorders and Treatments (14 papers) and Thyroid Disorders and Treatments (8 papers). Nicola Currò collaborates with scholars based in Italy, United States and Australia. Nicola Currò's co-authors include Mario Salvi, Guia Vannucchi, Irene Campi, Davide Dazzi, Paolo Beck‐Peccoz, Claudio Guastella, Danila Covelli, Simona Simonetta, Roberto Ratiglia and Lorenzo Pignataro and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Nicola Currò

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Currò Italy 15 1.1k 775 427 297 109 28 1.3k
Simona Simonetta Italy 7 551 0.5× 417 0.5× 210 0.5× 136 0.5× 57 0.5× 7 647
James W. Gigantelli United States 8 481 0.4× 282 0.4× 216 0.5× 185 0.6× 74 0.7× 17 680
N. Matheis Germany 14 324 0.3× 376 0.5× 138 0.3× 48 0.2× 84 0.8× 17 715
J. S. Kennerdell United States 15 352 0.3× 222 0.3× 232 0.5× 214 0.7× 75 0.7× 28 665
Ikuyo Miyake Japan 14 242 0.2× 325 0.4× 99 0.2× 38 0.1× 56 0.5× 19 611
L. L. Seah Singapore 9 253 0.2× 222 0.3× 98 0.2× 50 0.2× 34 0.3× 13 391
Lara Frommer Germany 14 200 0.2× 403 0.5× 40 0.1× 38 0.1× 39 0.4× 25 693
Ildikó Molnár Hungary 12 168 0.2× 186 0.2× 55 0.1× 17 0.1× 45 0.4× 38 433
P. Martin van Hagen Netherlands 9 121 0.1× 87 0.1× 75 0.2× 27 0.1× 34 0.3× 19 339
M Hamédani Switzerland 8 117 0.1× 53 0.1× 132 0.3× 36 0.1× 29 0.3× 26 278

Countries citing papers authored by Nicola Currò

Since Specialization
Citations

This map shows the geographic impact of Nicola Currò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Currò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Currò more than expected).

Fields of papers citing papers by Nicola Currò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Currò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Currò. The network helps show where Nicola Currò may publish in the future.

Co-authorship network of co-authors of Nicola Currò

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Currò. A scholar is included among the top collaborators of Nicola Currò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Currò. Nicola Currò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muller, Ilaria, Nicola Currò, Lorenzo Pignataro, et al.. (2024). Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab. European Thyroid Journal. 13(2). 2 indexed citations
2.
Muller, Ilaria, et al.. (2023). Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination. The Journal of Clinical Endocrinology & Metabolism. 109(2). 516–526. 11 indexed citations
3.
Campi, Irene, Guia Vannucchi, Ilaria Muller, et al.. (2022). Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy. Frontiers in Endocrinology. 12. 790246–790246. 12 indexed citations
4.
Vannucchi, Guia, Irene Campi, Nicola Currò, et al.. (2021). Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy. Zenodo (CERN European Organization for Nuclear Research).
5.
Campi, Irene, Nicola Currò, Guia Vannucchi, et al.. (2020). Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions. Thyroid. 31(2). 280–287. 7 indexed citations
6.
Vannucchi, Guia, Irene Campi, Danila Covelli, et al.. (2020). Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy. Thyroid. 31(5). 821–828. 36 indexed citations
7.
8.
9.
Covelli, Danila, Guia Vannucchi, Irene Campi, et al.. (2015). Statins May Increase the Risk of Liver Dysfunction in Patients Treated With Steroids for Active Graves' Orbitopathy. The Journal of Clinical Endocrinology & Metabolism. 100(5). 1731–1737. 12 indexed citations
10.
Campi, Irene, Delfina Tosi, Stefania Rossi, et al.. (2015). B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases. Thyroid. 25(9). 1043–1049. 27 indexed citations
11.
Currò, Nicola, Danila Covelli, Guia Vannucchi, et al.. (2014). Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy. Thyroid. 24(5). 897–905. 75 indexed citations
12.
Salvi, Mario, Guia Vannucchi, Nicola Currò, et al.. (2014). Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 100(2). 422–431. 275 indexed citations
13.
Vannucchi, Guia, Danila Covelli, Irene Campi, et al.. (2013). The therapeutic outcome of intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor. European Journal of Endocrinology. 170(1). 55–61. 42 indexed citations
14.
Campi, Irene, Guia Vannucchi, Andrea Minetti, et al.. (2013). A Quantitative Method for Assessing the Degree of Axial Proptosis in Relation to Orbital Tissue Involvement in Graves' Orbitopathy. Ophthalmology. 120(5). 1092–1098. 14 indexed citations
15.
Bartalena, Luigi, G. E. Krassas, Wilmar M. Wiersinga, et al.. (2012). Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy. The Journal of Clinical Endocrinology & Metabolism. 97(12). 4454–4463. 252 indexed citations
16.
Vannucchi, Guia, Irene Campi, Marco Bonomi, et al.. (2010). Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions. Clinical & Experimental Immunology. 161(3). 436–443. 44 indexed citations
17.
Vannucchi, Guia, Irene Campi, Danila Covelli, et al.. (2009). Graves’ Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis. The Journal of Clinical Endocrinology & Metabolism. 94(9). 3381–3386. 68 indexed citations
18.
Veraldi, Stefano, Silvia Bottini, Nicola Currò, & Raffaele Gianotti. (2009). Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis. International Journal of Infectious Diseases. 14. e230–e232. 23 indexed citations
19.
Salvi, Mario, Guia Vannucchi, Irene Campi, Nicola Currò, & P. Beck‐Peccoz. (2008). New immunomodulators in the treatment of Graves’ ophthalmopathy. Annales d Endocrinologie. 69(2). 153–156. 10 indexed citations
20.
Salvi, Mario, Guia Vannucchi, Irene Campi, et al.. (2007). Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. European Journal of Endocrinology. 156(1). 33–40. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Simonetta Breakdown of academic impact, for papers by James W. Gigantelli Breakdown of academic impact, for papers by N. Matheis Breakdown of academic impact, for papers by J. S. Kennerdell Breakdown of academic impact, for papers by Ikuyo Miyake Breakdown of academic impact, for papers by L. L. Seah Breakdown of academic impact, for papers by Lara Frommer Breakdown of academic impact, for papers by Ildikó Molnár Breakdown of academic impact, for papers by P. Martin van Hagen Breakdown of academic impact, for papers by M Hamédani
Rankless by CCL
2026